Adaptive Biotechnologies Corp (ADPT)

Adaptive Biotechnologies Corp (ADPT) is a Diagnostics & Research company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.9B; returns 1 day +4.5%, 1 week +6.2%, 1 year +48.7%.

Adaptive Biotechnologies Corporation is a commercial-stage biotechnology company focused on advancing immune-driven medicine by leveraging the inherent biology of the adaptive immune system to transform disease diagnosis and treatment. The company primarily operates through two segments: Minimal Residual Disease (MRD) and Immune Medicine.

Groups ADPT belongs to

• Biotechnology
• Recent Reverse Splits
• Life Sciences
• Healthcare
• Oncology
• Health Diagnostics and Imaging
• Immunotherapy
• Commercial Stage
• Commercial Stage Biotech
• Hematology
• Drug Discovery

ADPT financial model: income statement, cash flow and balance sheet